Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
Launched by UNIVERSITY OF GEORGIA · May 15, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The "Renewed Recovery" trial is studying a new online program designed to help people who are recovering from alcohol use disorder (AUD) after completing standard outpatient treatment. This program, called Mindfulness-Based Relapse Prevention (MBRP), aims to support individuals during their recovery journey by providing helpful resources and tools through a website. Participants will engage in an 8-week program that includes self-guided lessons, videos, and group meditation sessions via Zoom. Researchers want to see if this online approach helps people stay on track with their recovery and improves their overall well-being.
To be eligible for the trial, participants must be over 18 years old, have recently completed or be about to finish outpatient treatment for alcohol use, have internet access, and show signs of alcohol-related issues. They will take part in surveys to share their experiences with the program and track their progress in areas like anxiety, coping skills, and the chance of relapse. This study is currently recruiting participants and aims to gather valuable feedback to improve the program for future users.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Currently leaving standard outpatient treatment within 1 week of the scheduled intervention start date, or has completed standard outpatient treatment within the past month
- • Has access to the internet
- • Scored 8 or above on the Alcohol Use Disorders Identification Test (AUDIT), or self-identifies as having been in treatment for alcohol use
- Exclusion Criteria:
- • Currently experiencing psychosis
- • Currently experiencing dementia
- • Does not have access to the internet
- • Has not recently completed or left standard outpatient treatment within the specified timeline
- • Does not meet criteria for alcohol use disorder
About University Of Georgia
The University of Georgia (UGA) is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UGA leverages its extensive resources and expertise in various fields, including medicine, pharmacy, and public health, to conduct rigorous and impactful research. The university is committed to ethical standards and participant safety, ensuring that all clinical trials are designed to generate reliable data that can inform clinical practice and policy. UGA's focus on education and community engagement further enhances its role as a vital contributor to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Macon, Georgia, United States
Winder, Georgia, United States
Patients applied
Trial Officials
Jessica L Muilenburg, PhD
Principal Investigator
University of Georgia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported